Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

8,238 stories indexed, page 45 of 138

🇨🇦Researchgenomecanada.ca

Canada’s hardest problems demand a different kind of science. Here’s how we work.

Genome CanadaOriginal source
🇫🇷Researchchu-lyon.fr

Hub Prévention cardiovasculaire et métabolique : et si vous deveniez acteur de votre santé ?

Hospices Civils de LyonOriginal source
🇺🇸CROmedidata.com

Clinical Trial Participation: How Can We Make it More Feasible?

Medidata SolutionsOriginal source
🇯🇵Researchriken.jp

RIKEN invests into SAIMEMORY Corp

RIKENOriginal source
🌍Researchunityhealth.to

Gift of Life: St. Michael’s Hospital hits significant milestone with 50 living kidney transplants in one year

St. Michael's Hospital (Toronto)Original source
🌍Researchpremier-research.com

Understanding CSR vs Safety Narratives in Clinical Research

Premier ResearchOriginal source
🇺🇸CROir.criver.com

Charles River Highlights Effectiveness of VCGs in Toxicology

Charles River LaboratoriesOriginal source
🌍Mediaevaluate.com

How do Forecasting Approaches and Methodologies Change Through the Product Lifecycle?

Evaluate VantageOriginal source
🇬🇧Researchuclh.nhs.uk

Groundbreaking bowel cancer trial follow-up shows zero relapses

University College London Hospitals (UCLH)Original source
🇺🇸Industrybiomarin.com

Jake Birecki Makes Space for Passion, Purpose and Play

BioMarin PharmaceuticalOriginal source
🇩🇪Mediacharite.de

bio:cap 2026: Wo KI auf Life-Science trifft

Charité - Universitätsmedizin Berlin (EN)Original source
🌍Industrycibeles.com.uy

TEMPO 420 SC

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uy

TEMPO 420 SC

Cibeles (Uruguay)Original source
🇪🇸Researchcnic.es

Identifican un biomarcador que mejora la predicción del riesgo en una forma grave de insuficiencia cardiaca

CNIC Spain CardiovascularOriginal source
🌍Researchuab.edu

Neurologists expand global health program to bring specialized care in Kenya

University of Alabama at BirminghamOriginal source
🌍CROcrucialdatasolutions.com

Where Study Simulation Fits in Clinical Trials

TrialKitOriginal source
🇯🇵CROen.cmicgroup.com

Outsourcing in Clinical Trials (OCT) UK & Ireland 2026

CMIC Group JapanOriginal source
🇬🇧CDMOergomedgroup.com

Ergomed Clinical Research Named Finalist in Fierce Outsourcing Awards 2026 for “Clinical Trial Management”

ErgomedOriginal source
🇬🇧Researchquadram.ac.uk

How genomics clarifies a complex Campylobacter picture

Quadram Institute (Bioscience)Original source
🌍Researchunityhealth.to

Unity Health Toronto strengthens coordinated care for patients with high-risk pregnancies

St. Michael's Hospital (Toronto)Original source
🌍Industryexozymes.com

Podcast: CEO Heltzen @ Executive Insights for Life Sciences Innovators

eXoZymesOriginal source
🌍CROtrinetx.com

What Makes Real-World Evidence Credible? Insights from Academic Research

TriNetXOriginal source
🇬🇧Industrygsk.com

Blenrep (belantamab mafodotin) approved in China for treatment of 2L+ relapsed/refractory multiple myeloma

GSK NewsOriginal source
🇺🇸Industryinvestors.amneal.com

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Amneal Pharmaceuticals RSSOriginal source
🇯🇵Industrysumitomo-pharma.com

Notice Regarding Determination of Issue Price, Selling Price and Other Matters

Sumitomo PharmaOriginal source
🇯🇵Researchmed.kyoto-u.ac.jp

Research position at Suzuki Lab, Center for Cancer Immunotherapy and Immunobiology (CCII), Kyoto University

Kyoto University Faculty of MedicineOriginal source
🌍Regulatorypharmac.govt.nz

Agenda for May 2026 Pharmacology and Therapeutics advisory committee (PTAC) meeting

Pharmac New ZealandOriginal source
🌍Industrymenicon.com

Scleral lens “Time XL” acquires approval in China - New option for patients with irregular cornea available in the Chinese market -

MeniconOriginal source
🇯🇵Researchkyoto-u.ac.jp

News Published on 2026/04/20 タグ University News Kyoto University releases "Creating our future together: KyotoU Future Commons"

Kyoto UniversityOriginal source
🌍Industryrss.globenewswire.com

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GH ResearchOriginal source
🇺🇸Industryir.unither.com

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

United TherapeuticsOriginal source
🌍Industrybioinformaticsonline.com

Update for Jitendra Narayan

BioInformatics OnlineOriginal source
🌍Industrybioinformaticsonline.com

Update for Jitendra Narayan

BioInformatics OnlineOriginal source
🌍Industryenanta.com

Zelicapavir Demonstrates High Clinical and Functional Barrier Against Antiviral Resistance: Results from a Randomized Double-Blind Placebo-Controlled Pediatric RSV Antiviral Clinical Trial

Enanta PharmaceuticalsOriginal source
🌍Industryenanta.com

Zelicapavir Decreases Symptom Duration, Hospitalization and Viral Load in a Global, Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of High-Risk Adults with RSV

Enanta PharmaceuticalsOriginal source
🌍Industryenanta.com

Potent STAT6 Inhibitor EPS-3903 Has Excellent Preclinical Pharmacokinetics Enabling Sustained STAT6 Inhibition with Once-Daily Oral Dosing in Humans

Enanta PharmaceuticalsOriginal source
🇺🇸Researchatlasventure.com

In hopeful sign for biotech, obesity treatment firm Kailera raises $625 million in upsized IPO

Atlas VentureOriginal source
🇺🇸Researchatlasventure.com

Kailera nets $625M in one of biotech’s biggest-ever IPOs

Atlas VentureOriginal source
🌍Industryenanta.com

Discovery and Characterization of a Potent and Selective Oral Inhibitor of STAT6 for the Treatment of Allergic Diseases

Enanta PharmaceuticalsOriginal source
🇨🇦Industryir.zymeworks.com

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

ZymeworksOriginal source
🌍universitynews.mit.edu

Professor Michael Laub and MIT alumni named 2025 AAAS Fellows

MIT Biology NewsOriginal source
🇨🇦Researchnews.ubc.ca

UBC researchers aim to deliver earlier warnings on the toxic drug supply

University of British ColumbiaOriginal source
🌍Devicescontextflow.com

contextflow collaborates with VUNO and Mesalvo to advance cardiac arrest prediction solution

contextflow (ADVANCE Chest CT Lung)Original source
🌍Industryenanta.com

EPS-3903 Is a Potent and Selective Oral STAT6 Inhibitor That Blocks Th2 Inflammation in an Ovalbumin Asthma Mouse Model

Enanta PharmaceuticalsOriginal source
🇺🇸Devicesviz.ai

Viz.ai Wins Gold Edison Award™ for Advancing AI-Driven Clinical Workflows to Improve Hemorrhage Care

Viz.aiOriginal source
🌍Industryexozymes.com

Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturing

eXoZymesOriginal source
🇬🇧Researchphar.cam.ac.uk

Pharmacology at the Cambridge Festival!

Cambridge Pharma ResearchOriginal source
🌍Industryaspenpharma.com

Aspen Australia participates in the 2026 APP Conference

Aspen PharmacareOriginal source
🇬🇧Researchpirbright.ac.uk

New publication describes the vesicular disease outbreaks of Seneca Valley virus in England in 2022

The Pirbright Institute (Virology)Original source
🇩🇪Mediacharite.de

Grundlegend neuer Therapieansatz gegen Mukoviszidose: Nanobody repariert Zelldefekt

Charité - Universitätsmedizin Berlin (EN)Original source
🇩🇪Researchcharite.de

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect

Charité - Universitätsmedizin Berlin (EN)Original source
🌍Researchpnas.org

More information leads to more accurate beliefs—except in echo chambers

PNASOriginal source
🌍Industryamarin.co.th

เตรียมตัวพบกับ! งานบ้านและสวนแฟร์ ขอนแก่น บ้านเฮามักม่วน 2026

Amarin CorporationOriginal source
🌍Industryamarin.co.th

อมรินทร์เปิดเวทีค้นหา “นักพัฒนาชุมชนพอเพียงรุ่นใหม่”

Amarin CorporationOriginal source
🇯🇵Industrysanten.com

Santen China Signs Exclusive Distribution and Promotion Agreement for Five Marketed Glaucoma Products in the Chinese Mainland

Santen PharmaceuticalOriginal source
🇪🇸Researchcnic.es

Michael Reth: “Las personas con dislexia están especializadas en explorar lo desconocido”

CNIC Spain CardiovascularOriginal source
🇺🇸CDMOinvestors.emergentbiosolutions.com

Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

Emergent BioSolutionsOriginal source
🇺🇸Researchbroadinstitute.org

Clinical trial of a prion disease drug candidate begins enrolling participants

Broad Institute NewsOriginal source
🇺🇸Industry4gclinical.com

From “Must-Have” to Meaningful Progress: Creativity & Innovation Day

4G ClinicalOriginal source